Respiratory Diagnostics

Respiratory Diagnostics

Global Respiratory Diagnostics Market to Reach US$9.8 Billion by 2030

The global market for Respiratory Diagnostics estimated at US$7.2 Billion in the year 2023, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Mechanical Tests, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Imaging Tests segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.5% CAGR

The Respiratory Diagnostics market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Respiratory Diagnostics Market - Key Trends and Drivers Summarized

Respiratory Diagnostics: Advancing the Detection of Lung Diseases

Respiratory diagnostics are revolutionizing the detection and management of lung diseases by providing more accurate, non-invasive, and rapid testing methods. These diagnostics encompass a range of tests, including spirometry, blood gas analysis, and imaging techniques, that assess lung function and detect conditions such as tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and lung infections. Early detection of respiratory diseases is crucial for effective treatment and management, as many of these conditions can lead to severe complications if left untreated. With advancements in diagnostic technology, healthcare providers can now diagnose respiratory conditions with greater precision, leading to improved patient outcomes and a higher quality of life for those affected.

What Technological Advancements Are Enhancing Respiratory Diagnostics?

Technological advancements are significantly enhancing the capabilities of respiratory diagnostics, making them more accurate, accessible, and user-friendly. Innovations in imaging technology, such as high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI), allow for detailed visualization of lung structures, enabling the early detection of diseases that may not be apparent on standard X-rays. Additionally, the development of portable and point-of-care diagnostic devices, such as handheld spirometers and pulse oximeters, has made it easier for healthcare providers to conduct tests in various settings, including primary care offices and patient homes. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), have also improved the ability to detect specific pathogens and genetic markers associated with respiratory diseases. These technological innovations are driving the adoption of respiratory diagnostics, providing more comprehensive and accurate assessments of lung health.

What Are the Key Applications and Benefits of Respiratory Diagnostics?

Respiratory diagnostics are used in a wide range of clinical settings to assess lung function, diagnose respiratory diseases, and monitor treatment effectiveness. In primary care, spirometry is a common diagnostic tool used to measure lung capacity and airflow, helping to diagnose conditions like asthma and COPD. In hospitals, more advanced tests such as blood gas analysis and HRCT scans are used to assess the severity of respiratory conditions and guide treatment decisions. The use of molecular diagnostics in respiratory testing has become increasingly important, particularly in identifying the specific pathogens causing respiratory infections, enabling targeted treatment. The primary benefits of respiratory diagnostics include early detection of lung diseases, improved accuracy in diagnosis, and better monitoring of disease progression and treatment outcomes. These advantages make respiratory diagnostics a critical component of modern healthcare, supporting better patient care and disease management.

What Factors Are Driving the Growth in the Respiratory Diagnostics Market?

The growth in the Respiratory Diagnostics market is driven by several factors. The increasing prevalence of respiratory diseases, such as asthma, COPD, and lung infections, is a significant driver, as these conditions create a growing demand for accurate and reliable diagnostic tools. Technological advancements, particularly in imaging, molecular diagnostics, and point-of-care devices, are also propelling market growth by enhancing the capabilities and accessibility of respiratory diagnostics. The rising awareness of the importance of early detection and management of respiratory conditions is further boosting demand for these diagnostics, as early intervention can prevent complications and improve patient outcomes. Additionally, the ongoing impact of the COVID-19 pandemic has highlighted the critical need for effective respiratory diagnostics, driving further investment and innovation in this field. These factors, combined with the continuous advancement of medical technology, are driving the sustained growth of the Respiratory Diagnostics market.

Select Competitors (Total 43 Featured) -
  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cosmed Srl
  • Philips Healthcare
  • SDI Diagnostics
  • Seegene, Inc.
  • Thermo Fisher Scientific, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Respiratory Diagnostics: Overview & Outlook
Respiratory Diagnostics – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Mounting Burden of Respiratory Diseases: Major Driver
Pulmonary Function Test: Major Category
Imaging Tests Gain Traction
CT Screening for Improved Pulmonary Pathology
Bronchoscopy & Laryngoscopy for Evaluating the Airway Directly
Rising Cost of Medical Treatment Deters Growth
Rising Prevalence of Respiratory Diseases Propels Market Growth
Increasing Use of Diagnostic Tests in Early Detection and Disease Management Expands Addressable Market Opportunity
Technological Advancements in Imaging and Molecular Diagnostics Strengthen Market Position
Growing Focus on Personalized Medicine and Targeted Therapies Drives Adoption of Respiratory Diagnostics
Surge in Demand for Point-of-Care and Rapid Testing Solutions Generates New Opportunities
Development of Non-Invasive and Minimally Invasive Diagnostic Tools Sustains Market Growth
Expanding Applications in Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throws Spotlight on Market Potential
Rising Adoption of Respiratory Diagnostics in Homecare Settings Propels Market Expansion
Surge in Demand for Diagnostic Solutions Amidst Global Respiratory Disease Outbreaks Expands Market Horizons
Growing Awareness of the Importance of Early Diagnosis in Improving Patient Outcomes Drives Market Adoption
Innovations in Artificial Intelligence and Machine Learning for Diagnostic Accuracy Generate New Market Opportunities
Rising Demand for Respiratory Diagnostics in Emerging Healthcare Markets Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Tuberculosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Chronic Obstructive Pulmonary Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Instruments & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Services & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Mechanical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Molecular Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 34: World Respiratory Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 35: World Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
JAPAN
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
CHINA
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
EUROPE
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
FRANCE
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
GERMANY
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
UNITED KINGDOM
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
SPAIN
TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Spain 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Spain 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Spain 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
RUSSIA
TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Russia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Russia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Russia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
AUSTRALIA
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: Australia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: Australia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: Australia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
INDIA
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: India Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: India 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: India Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: India 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: India Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: India 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: South Korea 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: South Korea 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: South Korea 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
LATIN AMERICA
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Latin America 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
ARGENTINA
TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Argentina 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Argentina 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Argentina 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
BRAZIL
TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Brazil 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Brazil 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Brazil 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
MEXICO
TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Mexico 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Mexico 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Mexico 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
MIDDLE EAST
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Middle East 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
IRAN
TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Iran 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Iran 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Iran 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
ISRAEL
TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Israel 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Israel 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Israel 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: UAE 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: UAE 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: UAE 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
AFRICA
Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 304: Africa 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 307: Africa 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 310: Africa 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings